Healthcare entity

Everett Cunningham

Person

medical-devices is the sole category represented across all 1 tracked stories. Centers for Medicare & Medicaid Services is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 6 original sources per story, versus 2.5 across the same-window beat baseline.

Last mentioned: Mar 4, 2026

Entity pulse

Recent coverage · Everett Cunningham

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Everett Cunningham

medical-devices is the sole category represented across all 1 tracked stories. Centers for Medicare & Medicaid Services is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 6 original sources per story, versus 2.5 across the same-window beat baseline. At 6, the average consequence score sits above the same-window beat average of 5.9. We currently track 1 Healthcare story that mention Everett Cunningham, all published on March 4, 2026.

Stories tracked
1
Sources per story
6

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 22 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Everett Cunningham. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Earnings Call

    Management confirms CMS reimbursement rate of $897 and 2025 assay expansion.

  2. FDA Submission

    510(k) premarket notification submitted for Lucent AD Complete.

  3. Q4 2025 Close

    Quanterix reports $43.9M in revenue with 25% YoY growth.

Stories mentioning Everett Cunningham 1

Medical Devices Positive

Quanterix Secures CMS Reimbursement for Alzheimer’s Test Amid Q4 Growth

Quanterix reported a 25% year-over-year revenue increase to $43.9 million in Q4 2025, driven by a surge in diagnostics partner revenue and critical regulatory milestones. The company achieved a commercial breakthrough with a $897 CMS reimbursement rate for its Lucent AD Complete test, positioning it for large-scale clinical adoption.

6 sources

Everett Cunningham is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.